ABOUT Amyloidosis
Africa
25+ 15k 3k years
experience
TOTAL
PEOPLE HELPED
DOCTORS
TRAINED
Building a pan-African movement to improve awareness, diagnosis, and care for amyloidosis. GET INVOLVED
about Amyloidosis
Africa
25+ 15k 3K years
experience
TOTAL
PEOPLE HELPED
DOCTORS
TRAINED
Working with patients, clinicians, and researchers to make amyloidosis visible across Africa. LEARN MORE
{{current_slide_index}}/{{total_slide_count}} keyboard_arrow_down keyboard_arrow_up
Cardiac amyloidosis awareness initiative advancing early diagnosis and research across Africa Amyloidosis Africa pan-African initiative for awareness, research, and education
Cardiologists united across Africa to tackle cardiac amyloidosis.
0 +
Amyloidosis Africa initiative

Why Amyloidosis Africa Was Born

Amyloidosis Africa is a pan-African initiative that brings together cardiologists from across the continent to address the growing but hidden burden of cardiac amyloidosis. Launched by  CRK Clinical Research Key, we aim to raise awareness, educate health professionals, and drive continent-wide research collaboration for early diagnosis and improved patient care.

01

The Start

Amyloidosis Africa began as a clinical collaboration between cardiologists in Kenya, driven by the growing concern of underdiagnosed cardiac amyloidosis in African populations.

02

Growing Together

With support from national societies and research networks, we expanded across Africa, uniting doctors, researchers, and policymakers under one mission: equity in rare disease care.

03

Today

We now serve as a central platform for awareness campaigns, training programs, policy advocacy, and research, shining a light on a once-forgotten disease.

Our Commitment

Continental Engagement

We're working daily with clinicians and institutions across Africa to elevate the diagnosis and treatment of cardiac amyloidosis.

Guidance and support for families affected by amyloidosis

Awareness Campaigns

We develop community outreach and clinical red-flag education to raise awareness across all African regions.

Patient-centered care for cardiac amyloidosis

Policy & Research

We advocate for rare disease inclusion in national plans and support African-led amyloidosis research.

Education & Training

We create diagnostic toolkits and CPD resources tailored to African healthcare settings.

Improving recognition of rare cardiovascular diseases in Africa

Patient-Centered

We work toward accessible testing, earlier diagnosis, and support systems for patients and their families.

ABOUT US

Our Mission at Amyloidosis Africa

Amyloidosis Africa is dedicated to:

  • Raising awareness of ATTR amyloidosis across Africa

  • Promoting early and accurate diagnosis

  • Educating healthcare professionals through evidence-based programs

  • Supporting research, registries, and quality improvement initiatives

  • Advocating for equitable access to diagnostics and care

LORE
0
IPSU
0
DOLO
0
SIT
0
Patient-centered care for cardiac amyloidosis

Healthcare professionals

Improve recognition of red-flag features and align practice with international standards from the European Society of Cardiology and American Heart Association .

Improving recognition of rare cardiovascular diseases in Africa

Patients and families

Seek evaluation for persistent or unexplained symptoms and learn from trusted organizations such as the Amyloidosis Foundation .

Hospitals and institutions

Collaborate to develop referral pathways, registries, and diagnostic capacity across African health systems.

Guidance and support for families affected by amyloidosis

Researchers and policymakers

Support African-led data generation to ensure representation in global amyloidosis research.

Early recognition saves lives.

Rare does not mean invisible.

Voices From

Amyloidosis Africa

John Dawod

Dr. John Heshmat

We are building a continent-wide network of cardiologists committed to improving care for patients with amyloidosis. This collaboration is long overdue and necessary.

Prof. Leonard Ngunga

Cardiac amyloidosis is no longer a rare disease, it’s a rarely diagnosed one. Through Amyloidosis Africa, we are reshaping how Africa detects and manages this hidden epidemic.

Voices From Amyloidosis Africa

Rated 5 out of 5
Cardiac amyloidosis is no longer a rare disease, it’s a rarely diagnosed one. Through Amyloidosis Africa, we are reshaping how Africa detects and manages this hidden epidemic.

Prof. Leonard Ngunga


President, Kenya Cardiac Society
AMYLOIDOSIS AFRICA

Check our causes

Amyloidosis Medical Education

We deliver evidence-based medical education to healthcare professionals across Africa to strengthen early diagnosis and improve patient outcomes.

Pan-African Research Collaboration

We connect researchers and clinicians across Africa to collaborate on amyloidosis research, share data, and strengthen multicenter African-led studies.

Amyloidosis Advocacy

We advocate for the recognition of amyloidosis as a health priority in Africa, promoting equitable access to diagnosis, care, and policy support.

Amyloidosis Awareness

We raise awareness of amyloidosis across Africa to improve early recognition, reduce misdiagnosis, and challenge the myth that the disease is rare.

Amyloidosis Clinical Research

We advance Africa-led clinical research to improve understanding, diagnosis, and outcomes of amyloidosis, ensuring African patients are represented in global evidence.

Quality Improvement & Implementation

We implement quality improvement initiatives to reduce diagnostic delays, improve clinical pathways, and strengthen amyloidosis care within African health systems.

Patient Support

We support patients and families by improving access to reliable information, guidance, and navigation throughout the amyloidosis care journey.

Our Commitment Is Better Outcomes for Patients

We work across Africa to improve awareness, early diagnosis, research, and access to care for people affected by amyloidosis.

Contacts